Investing.com - Teva ADR reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Teva ADR announced earnings per share of $0.77 on revenue of $4.10B. Analysts polled by Investing.com anticipated EPS of $0.726 on revenue of $4.29B.
Teva ADR shares are up 3.5% from the beginning of the year and are trading at $8.29 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Teva ADR follows other major Healthcare sector earnings this month
Teva ADR's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar